Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Cardiovascular Diseases D002318 24 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Central Nervous System Diseases D002493 10 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Cholecystitis D002764 8 associated lipids
Cholestasis D002779 23 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Borin ML et al. [Relation between the changes in Na+/H+-exchange and cytoplasmic Ca levels in platelet activation]. 1988 Biull Eksp Biol Med pmid:2844320
Joseph R et al. Cytosolic ionized calcium homeostasis in platelets: an abnormal sensitivity to PAF-activation in migraine. 1988 Headache pmid:2844693
Arnoux B et al. Effect of PAF-acether in non-human primates. 1988 Prog. Clin. Biol. Res. pmid:2837781
Livio M et al. Role of platelet-activating factor in primary hemostasis. 1988 Am. J. Physiol. pmid:2837916
Hoffman DR et al. Synthesis of platelet activating factor by cholinephosphotransferase in developing fetal rabbit lung. 1988 Lipids pmid:2897059
Leff AR Neurohumoral regulation of airway contractile responses. 1988 Chest pmid:2897271
Bachelet M et al. Interaction between PAF-acether and drugs that stimulate cyclic AMP in guinea-pig alveolar macrophages. 1988 Eur. J. Pharmacol. pmid:2840303
Crouch MF and Lapetina EG No direct correlation between Ca2+ mobilization and dissociation of Gi during platelet phospholipase A2 activation. 1988 Biochem. Biophys. Res. Commun. pmid:3132162
Russell JA et al. Changes in the levels of bioactive components of cotton bracts accompanying senescence. 1988 Lung pmid:3132575
Martins MA et al. Intravenous injections of PAF-acether induce platelet aggregation in rats. 1988 Eur. J. Pharmacol. pmid:3135199
Peers SH Dexamethasone inhibits platelet activating factor-induced inflammation in the paw but not the pleural cavity of rats. 1988 Eur. J. Pharmacol. pmid:3136026
Mangold HK Synthesis of biologically active ether lipids. 1988 Prog Biochem Pharmacol pmid:3136454
Ferrell JE et al. Membrane bilayer balance and platelet shape: morphological and biochemical responses to amphipathic compounds. 1988 Biochim. Biophys. Acta pmid:3355815
López-Farré A et al. Glomeruli from ischemic rat kidneys produce increased amounts of platelet activating factor. 1988 Biochem. Biophys. Res. Commun. pmid:3358756
Valone FH and Epstein LB Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma. 1988 J. Immunol. pmid:3141509
Berti F et al. New pharmacological data on the bronchospasmolytic activity of bamifylline. 1988 Arzneimittelforschung pmid:3365275
Sun XM and Hsueh W Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. 1988 J. Clin. Invest. pmid:3366898
Barnes PJ Inflammatory mechanisms and nocturnal asthma. 1988 Am. J. Med. pmid:3041827
Camussi G and Salvidio G Platelet-activating factor in graft rejection. 1988 Prog Biochem Pharmacol pmid:3043426
Hénocq E PAF-acether and eosinophils. 1988 Prog Biochem Pharmacol pmid:3043428
Lagente V and Fortes ZB Role of PAF-acether in the vascular events of inflammation. 1988 Prog Biochem Pharmacol pmid:3043429
Cordeiro RS et al. Proinflammatory activity of platelet-activating factor: pharmacological modulation and cellular involvement. 1988 Prog Biochem Pharmacol pmid:3043430
Valone FH Platelet-activating factor binding and metabolism during human platelet aggregation. 1988 Thromb. Res. pmid:3400077
Bratton DL et al. Effects of platelet activating factor on calcium-lipid interactions and lateral phase separations in phospholipid vesicles. 1988 Biochim. Biophys. Acta pmid:3401478
Evans TW et al. Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man. 1988 Br. J. Pharmacol. pmid:3401633
Lagente V et al. Interference of the Paf antagonist Ro 19-3704 with Paf and antigen-induced bronchoconstriction in the guinea-pig. 1988 Br. J. Pharmacol. pmid:3401641
Groscurth P et al. Effects of platelet activating factor (PAF) on human citrated whole blood. 1988 Eur. J. Haematol. pmid:3402585
Tamura N et al. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation. 1988 J. Immunol. pmid:2848892
Pretolani M et al. Active immunization induces lung hyperresponsiveness in the guinea pig. Pharmacologic modulation and triggering role of the booster injection. 1988 Am. Rev. Respir. Dis. pmid:3202509
Pirotzky E and Braquet P [The role of the platelet-activating factor (PAF-acether) in renal pathology]. 1988 Presse Med pmid:2966954
Willuweit B and Aktories K Heparin and heparinoids impair adrenaline and platelet-activating factor but not thrombin-induced inhibition of adenylate cyclase and stimulation of GTP hydrolysis in human platelet membranes. 1988 Naunyn Schmiedebergs Arch. Pharmacol. pmid:2969081
Jancar S et al. Immune complex induced pancreatitis: effect of BN 52021, a selective antagonist of platelet-activating factor. 1988 Prostaglandins pmid:2969600
Wallace JL Release of platelet-activating factor (PAF) and accelerated healing induced by a PAF antagonist in an animal model of chronic colitis. 1988 Can. J. Physiol. Pharmacol. pmid:3167675
Stenson WF Platelet-activating factor and inflammatory bowel disease. 1988 Gastroenterology pmid:3169505
Valone FH et al. Enhanced human monocyte cytotoxicity by platelet-activating factor. 1988 Immunology pmid:3169845
Popovich KJ et al. Role of platelets in contraction of canine tracheal muscle elicited by PAF in vitro. 1988 J. Appl. Physiol. pmid:3170437
Moriyama T et al. Elevation of cytosolic free Ca2+ is directly evoked by thromboxane A2 in human platelets during activation with collagen. 1988 J. Biochem. pmid:3170519
Lagente V et al. Involvement of PAF-acether in anaphylactic bronchoconstriction induced in guinea pigs by aerosolized antigen. 1988 Int. Arch. Allergy Appl. Immunol. pmid:3338855
Imai T et al. Pulmonary hypertension and edema induced by platelet-activating factor in isolated, perfused rat lungs are blocked by BN52021. 1988 J. Lab. Clin. Med. pmid:3339274
Wichrowski B et al. Structure-activity relationship in PAF-acether. 4. Synthesis and biological activities of carboxylate isosteres. 1988 J. Med. Chem. pmid:3339611
Tilley JW et al. Pyrido[2,1-b]quinazolinecarboxamide derivatives as platelet activating factor antagonists. 1988 J. Med. Chem. pmid:3339617
Ferguson MK et al. Lymphatic smooth muscle responses to leukotrienes, histamine and platelet activating factor. 1988 J. Surg. Res. pmid:3339877
Homma H and Hanahan DJ Attenuation of platelet activating factor (PAF)-induced stimulation of rabbit platelet GTPase by phorbol ester, dibutyryl cAMP, and desensitization: concomitant effects on PAF receptor binding characteristics. 1988 Arch. Biochem. Biophys. pmid:2833174
Huang SJ et al. Platelet-activating factor-induced hydrolysis of phosphatidylinositol 4,5-bisphosphate stimulates the production of reactive oxygen intermediates in macrophages. 1988 Biochem. J. pmid:2833227
Brass LF et al. Interactions in platelets between G proteins and the agonists that stimulate phospholipase C and inhibit adenylyl cyclase. 1988 J. Biol. Chem. pmid:2833506
Blank ML et al. Stimulation of the de novo pathway for the biosynthesis of platelet-activating factor (PAF) via cytidylyltransferase activation in cells with minimal endogenous PAF production. 1988 J. Biol. Chem. pmid:2833508
Mencia-Huerta JM et al. [Effect of long-term administration of platelet activating factor on pulmonary response and morphology in the guinea pig]. 1988 Allerg Immunol (Paris) pmid:3245884
Rola-Pleszczynski M et al. Immune regulation by platelet-activating factor. I. Induction of suppressor cell activity in human monocytes and CD8+ T cells and of helper cell activity in CD4+ T cells. 1988 J. Immunol. pmid:2834440
Takeuchi N et al. The antagonist effects of compounds derived from khellactone on platelet-activating factor. 1988 Chem. Pharm. Bull. pmid:3245999
Hofmann B et al. Effect of specific antagonists on PAF-induced platelet aggregation and release of plasminogen activator. 1988 Biomed. Biochim. Acta pmid:3248103
Mest HJ et al. The arrhythmogenic effect of platelet activating factor (PAF) is inhibited by PAF antagonist and by substances influencing eicosanoids. 1988 Biomed. Biochim. Acta pmid:3248107
Kroegel C The potential pathophysiological role of platelet-activating factor in human diseases. 1988 Klin. Wochenschr. pmid:2839728
Leslie CC et al. Properties and purification of an arachidonoyl-hydrolyzing phospholipase A2 from a macrophage cell line, RAW 264.7. 1988 Biochim. Biophys. Acta pmid:3143418
Egger M et al. Human platelet electrorotation change induced by activation: inducer specificity and correlation to serotonin release. 1988 Biochim. Biophys. Acta pmid:3143424
Hammerschmidt DE et al. Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor. 1988 J. Lab. Clin. Med. pmid:2840477
Pitcock JA Morphometric studies of the renomedullary interstitial cells. 1988 Am. J. Med. Sci. pmid:3284348
Hwang SB et al. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor. 1988 J. Pharmacol. Exp. Ther. pmid:2841449
Parnham MJ PAF receptors. 1988 Prog Biochem Pharmacol pmid:2841664
Shkhvatsabaia IK et al. [Receptor-dependent regulation of the concentration of Ca2+ in the cytoplasm of thrombocytes in hypertensive patients]. 1988 Kardiologiia pmid:2842537
Stephens LR et al. Synthesis of myo-inositol 1,3,4,5,6-pentakisphosphate from inositol phosphates generated by receptor activation. 1988 Biochem. J. pmid:2845930
Ukena D and Sybrecht GW [Function of platelet activating factor in asthma]. 1988 Dtsch. Med. Wochenschr. pmid:2846251
Avdonin PV et al. Blocking of the receptor-stimulated calcium entry into human platelets by verapamil and nicardipine. 1988 Thromb. Res. pmid:3232128
Kiktev VG et al. [Calcium metabolism of the thrombocytes in ischemic heart disease]. 1988 Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR pmid:3233156
Yamada K et al. Highly sensitive gas chromatographic--mass spectrometric method for the determination of platelet-activating factor in human blood. 1988 J. Chromatogr. pmid:3235552
Yoshikawa D and Goto F [Interactions between platelet activating factor and leukotrienes during endotoxin shock in the rat]. 1988 Masui pmid:3236398
Wykle RL et al. Platelet-activating factor. 1988 Meth. Enzymol. pmid:3237085
Martin J Platelet-activating factor. 1988 Dec 24-31 Lancet pmid:2904593
Gebhardt BM et al. Modulation of in vitro immune reactions by platelet activating factor and a platelet activating factor antagonist. 1988 Jan-Feb Immunopharmacology pmid:2966135
Santos OF et al. [Platelet activating factor in nephrology: physiopathologic and therapeutic perspectives]. 1988 Jul-Aug Rev Paul Med pmid:3076976
Lakin KM et al. [Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation]. 1988 Jul-Aug Farmakol Toksikol pmid:2847936
Whatley RE et al. Endothelium from diverse vascular sources synthesizes platelet-activating factor. 1988 May-Jun Arteriosclerosis pmid:3130833
Di Marzo V et al. Neuropeptides and leukotriene biosynthesis: the effect of calcitonin, peptide histidine valine-42, helodermin, neuropeptide Y and galanin. 1988 May-Jun Neuropeptides pmid:2458537
Bellioni P et al. [Histomorphological changes in nasal polyps in patients with glucose metabolism disorders]. 1988 Nov-Dec Acta Otorhinolaryngol Ital pmid:3247845
Labrakis-Lazanas K et al. PAF of biological fluids in disease: blood levels in allergic rhinitis. 1988 Sep-Oct Haematologica pmid:3143636
Mencia-Huerta JM et al. Acute and long-term pulmonary effects of platelet-activating factor. 1989 Clin. Exp. Allergy pmid:2473829
Pretolani M et al. Limited interference of specific Paf antagonists with hyper-responsiveness to Paf itself of lungs from actively sensitized guinea-pigs. 1989 Br. J. Pharmacol. pmid:2474345
Espey LL et al. Decrease in ovarian platelet-activating factor during ovulation in the gonadotropin-primed immature rat. 1989 Biol. Reprod. pmid:2804200
Orlov SM et al. [Mechanism of suppression of human peripheral blood lymphocyte proliferation by platelet activation factor]. 1989 Biull Eksp Biol Med pmid:2804305
Spangenberg P et al. Blood platelet behaviour in patients with a type I diabetes mellitus. 1989 Exp. Clin. Endocrinol. pmid:2630313
Medeiros YS and Calixto JB Effect of PAF-acether on the reactivity of the isolated rat myometrium. 1989 Braz. J. Med. Biol. Res. pmid:2636008
Boughton-Smith NK et al. Relationship between PAF-acether and thromboxane A2 biosynthesis in endotoxin-induced intestinal damage in the rat. 1989 Prostaglandins pmid:2506613
Nakashima S et al. Mechanism of arachidonic acid liberation in platelet-activating factor-stimulated human polymorphonuclear neutrophils. 1989 J. Immunol. pmid:2545786
Dent G et al. Characterization of PAF receptors on human neutrophils using the specific antagonist, WEB 2086. Correlation between receptor binding and function. 1989 FEBS Lett. pmid:2537761
Pitton C et al. Presence of PAF-acether in human breast carcinoma: relation to axillary lymph node metastasis. 1989 J. Natl. Cancer Inst. pmid:2769781
Tolins JP et al. Role of platelet activating factor in endotoxemic acute renal failure in the male rat. 1989 J. Lab. Clin. Med. pmid:2538527
Kioka K et al. [Changes in production of platelet activating factor by adherent hepatocytes of mice with experimental liver failure]. 1989 Nihon Shokakibyo Gakkai Zasshi pmid:2770018
Goswami SK et al. Platelet-activating factor stimulates secretion of respiratory glycoconjugate from human airways in culture. 1989 J. Allergy Clin. Immunol. pmid:2478607
Sawyer DB and Andersen OS Platelet-activating factor is a general membrane perturbant. 1989 Biochim. Biophys. Acta pmid:2480815
Dorsch W et al. Antiasthmatic effects of onions. Prevention of platelet-activating factor induced bronchial hyperreactivity to histamine in guinea pigs by diphenylthiosulfinate. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2707885
Braquet P et al. The role of platelet-activating factor in cerebral ischemia and related disorders. 1989 Ann. N. Y. Acad. Sci. pmid:2672941
Nolte D [Platelet activating factor produces platelet activating factor, comes to nothing]. 1989 Med. Klin. (Munich) pmid:2755413
Joseph R and Welch KM Granulocytes, platelet activating factor, and stroke. 1989 Stroke pmid:2756548
Trebien HA and Calixto JB Pharmacological evaluation of rat paw oedema induced by Bothrops jararaca venom. 1989 Agents Actions pmid:2660497
Denizot Y et al. Paf-acether production by Escherichia coli. 1989 Biochem. Biophys. Res. Commun. pmid:2660796
Lister MD et al. Inhibition studies on the membrane-associated phospholipase A2 in vitro and prostaglandin E2 production in vivo of the macrophage-like P388D1 cell. Effects of manoalide, 7,7-dimethyl-5,8-eicosadienoic acid, and p-bromophenacyl bromide. 1989 J. Biol. Chem. pmid:2498315
Skvortsov AA et al. [New approaches to the study of thrombocyte aggregation in patients with dilated cardiomyopathy]. 1989 Ter. Arkh. pmid:2727928
Desquand S et al. Antigen-induced bronchopulmonary alterations in the guinea pig: a new model of passive sensitization mediated by mouse IgE antibodies. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2731996
Yanagihara Y et al. Immunopharmacological studies on TBX, a new antiallergic drug (3). Inhibitory effects on histamine release from lung fragments and bronchoconstriction in guinea pigs. 1989 Jpn. J. Pharmacol. pmid:2478743
Koenderman L et al. 1,2-Diacylglycerol accumulation in human neutrophils does not correlate with respiratory burst activation. 1989 FEBS Lett. pmid:2597277
Braquet P et al. Effect of platelet-activating factor on platelets and vascular endothelium. 1989 Semin. Thromb. Hemost. pmid:2546255